Canadian Pharmacy Residency Board

Address:
2075 Bayview Avenue
Toronto, ON, M4N 3M5

Director:
Dr. Danette Beechinor, BScPharm, PharmD
Phone: 416-480-6100 ext. 4494
Fax: 416-480-5887

Coordinator:
Dr. Alison Bond, HonBSc, BScPhm, PharmD, MSc
Phone: 416-480-6100 ext. 63654
Fax: 416-480-5887
 

Contact:
Alison Bond, HonBSc, BScPhm, PharmD, MSc
Phone: 416-480-6100 ext. 63654
Fax: 416-480-5887
Email: alison.bond@sunnybrook.ca

Interested applicants:
Please submit a letter of interest and a current curriculum vitae by January 15, 2025 to:
Danette Beechinor, Director of Pharmacy
Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Room 305
Toronto, ON, M4N 3M5
Email: danette.beechinor@sunnybrook.ca

Program

Type: Inpatient

Focus: Thromboembolism (TE)

Established in: 2019

Number of Position(s): 1

Application Deadline: January 15

Start Date: September 2025 (residents taken every 2 years)

Estimated Stipend: $75,000 per annum

Benefits: Yes

Vacation/holiday leave: 10 days

Education/Conference Leave: 5 days (Budget to be reviewed annually.  Conferences in North America will be considered, with a preference for Canadian conferences).

Program Highlights: The thromboembolism (TE) program is a comprehensive clinical service and academic program committed to excellence in patient care, education, research, and leadership in the area of thromboembolism and anticoagulant management. This year 2 residency program is built on the recognition that the prevention and management of thromboembolic disorders are important patient quality of care priorities for hospitalized and community patients.

This residency program is designed to provide pharmacists with the formal training necessary to become a leader in thromboembolism pharmacy practice by enhancing their clinical knowledge of the effective and safe use of antithrombotic medications through the provision of evidence-based direct patient care. Other goals of the program include enhancing individual skills and confidence so that the successful resident can become a thrombosis management practitioner, change agent, and leader in this area locally and/or regionally; as well as to develop project management and research skills through the completion of research projects in an area of relevance to thrombosis. The program includes comprehensive rotations in thromboembolism, cardiology, and stroke; with exposure to sub-specialty areas and patient populations such as pediatrics and peripheral arterial disease. 

Core/Required Rotations:

• Inpatient TE Service - Longitudinal 
• Outpatient Anticoagulant Management Clinic - Longitudinal
• Stroke
• Cardiology
• Research
• Teaching and Learning
• Leadership in Medication Safety

Elective Rotations:

• Inpatient TE Service (external)
• Outpatient TE and Peripheral Arterial Disease/PAD  (external)
• Hematology 
• Pediatric TE (external)

Required Credentials:

The applicant will be a registered pharmacist with one of the following:

1. Doctor of Pharmacy as a second professional degree (i.e. post-baccalaureate)
2. Master’s degree in Advanced Pharmacotherapy
3. Completion (or due to complete) an accredited year-1 Pharmacy residency

Program Affiliation: University of Toronto

Organization

Type: Tertiary Care, Academic Teaching Hospital

Number of beds: 1,325

Site(s): Sunnybrook Health Sciences Centre, external rotations available depending on availability
 

Graduates

2020-2021	Jennifer Pitman
2019-2020	Stephanie Carlin